Overview


According to FutureWise analysis, the market for Personalized Psychiatry is expected to grow with a CAGR of 10.60% over the forecast period 2024-2032, and reach a market value of US$ 7.93 billion by 2031.

Personalized psychiatry, also known as precision psychiatry or individualized psychiatry, is an approach to mental health care that aims to tailor treatments to each patient's specific characteristics and needs. This approach recognizes that mental disorders can have a wide range of underlying causalities, including genetic, environmental, and psychological factors, and that there is significant variability in how individuals respond to different treatments. Personalized psychiatry often involves assessing an individual's genetic makeup to identify specific genetic variations that may influence their risk for mental disorders or their response to particular treatments. This may involve techniques like genetic testing or studying gene expression patterns.

Personalized psychiatry has witnessed a remarkable evolution with the integration of various advanced technologies and services tailored to individual needs. Among these, software plays a pivotal role in facilitating advanced diagnostics, treatment planning, and therapy monitoring. Its adaptive algorithms analyze extensive datasets to offer customized insights, optimizing the treatment journey. Services, on the other hand, provide a holistic approach by combining therapeutic interventions, counseling, and support networks to address specific mental health concerns. EEG Biofeedback stands out as a pioneering technique, enabling real-time brainwave monitoring and training, which enhances self-regulation and cognitive performance. Wearables introduce continuous monitoring, allowing for early detection of physiological indicators linked to mental health, thereby enabling timely interventions. Brain stimulation devices, like transcranial magnetic stimulation (TMS) or transcranial direct current stimulation (tDCS), offer non-invasive neuromodulation techniques that can be tailored to target specific neural circuits, providing effective therapeutic options for various psychiatric conditions.

FutureWise Market Research has published a report that provides an insightful analysis personalized psychiatry market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts personalized psychiatry market estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • myStrength
  • Genomind
  • WayForward
  • BrightQuest
  • Peak Mental Wellness
  • Mindstrong, Pear Therapeutics
  • Akili Interactive
  • Emotiv
  • Neuronetrix
  • Medopad
  • Taliaz
  • Lucid Lane
  • MindX Sciences
  • Neurotrack
  • 7 Cups
  • Happify
  • Quartet
  • NOCD
  • Real

(Note: The list of the major players will be updated with the latest market scenario and trends)

The rising prevalence of mental health disorders worldwide has increased the demand for treatments that are more effective and tailored to individual patient profiles. This surge in demand for personalized psychiatry solutions arises from a collective recognition that one-size-fits-all approaches may not optimally address the diverse and nuanced nature of mental health conditions. As patients and healthcare providers alike seek more precise interventions, the personalized psychiatry market stands to benefit substantially from this paradigm shift, driving its sustained growth and advancement. Additionally, progress in understanding the genetic basis of mental disorders has paved the way for personalized treatment options and advancement in psychiatry. By identifying specific genetic markers associated with susceptibility to particular mental health conditions, healthcare providers may design interventions tailored to an individual's genetic makeup. This not only enhances the effectiveness of treatments but also minimizes potential side effects, marking a significant leap forward in mental healthcare and propelling the personalized psychiatry market to the forefront of innovation and patient-centered care. Moreover, the advent of advanced technologies like genomics, proteomics, and neuroimaging has revolutionized the landscape of psychiatric care. These sophisticated tools empower clinicians with unprecedented insights into the biological support of mental health disorders. Genomic analysis reveals complex genetic predispositions, proteomic studies illuminate molecular pathways, and neuroimaging provides vivid images of brain function. This wealth of data enables remarkably precise diagnoses and treatment planning, allowing healthcare providers to tailor interventions with an unparalleled level of accuracy. Therefore, this technological surge propels the personalized psychiatry market over the forecast period. However, the personalized psychiatry faces significant hurdles, mainly from complex ethical and regulatory considerations surrounding genetic testing and tailored treatments. Balancing the imperative for patient privacy and informed consent with the potential for invaluable insights from genetic data is challenging. Also, the high costs associated with personalized psychiatry, notably genetic testing and specialized diagnostics, pose a substantial barrier to accessibility. This financial burden may impede individuals, especially those from economically deprived regions, from benefiting fully from these advanced and transformative approaches to mental health care.

By Product Type

  • Software
  • Services
  • EEG Biofeedback
  • Blood Tests
  • Wearables
  • Brain Stimulation Devices
  • Others

By Condition

  • Depression & Anxiety
  • Bipolar Disorder
  • Addiction
  • Dementia
  • ADHD
  • OCD
  • Others

By End-User

  • Hospitals & Clinics
  • Academic Institutes & Research Centers
  • Homecare Settings
  • Specialty Clinics
  • Diagnostic Laboratories
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. This is primarily driven by factors such as the high adoption of advanced genomic testing, advances in artificial intelligence and machine learning, increasing awareness about mental health, and the development of advanced neuroimaging techniques, such as fMRI and PET scans in the US, are expected to fuel the target market. Moreover, the presence of key players, product launches, partnerships, and acquisitions are further driving the market growth over the forecast period. For instance, in January 2022, Happify partnered with Sanvello Health to merge digital mental health platforms. The partnership expands their ability to deliver clinically validated tools addressing stress, anxiety, and depression. Also, in January 2022, Akili Interactive launched EndeavorRx, the first FDA-cleared digital therapeutic for pediatric ADHD. EndeavorRx is delivered through a captivating video game experience designed to target and activate neural systems implicated in attentional function.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Personalized Psychiatry Market By Product Type, By Condition, By End-User, and By Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape, mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.  Market Introduction
    •   1. Objectives of the Study 
        2. Market Definition 
        3. Market Scope 
           3.1. Years Considered for the Study
           3.2. Market Covered
        4. Currency 
        5. Limitations 
        6. Stakeholders 

  • 2.  Research Methodology
    •   1. Research Data 
           1.1. Secondary Data
              1.1.1. Key Data from Secondary Sources
           1.2 Primary Data
              1.2.1. Key Data from Primary Sources
        3. Market Size Estimation 
        4. Market Breakdown and Data Triangulation 
        5. Assumptions for the Study 

  • 3.  Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights

  • 4.  Personalized Psychiatry Market Variables, Trends & Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Application Overview
        6. Regulatory Framework
           6.1. Reimbursement Framework
           6.2. Standards and Compliances

  • 5.  Market Overview
    •   1. Market Dynamics
           1.1. Market Driver Analysis
              1.1.1. Increasing focus of Personalized Psychiatry Market Companies on Brand Protection
              1.1.2. Untapped Opportunities in Emerging Regions
           1.2. Market Restraint Analysis
              1.2.1. High Cost Associated with Implementation of Predictive Analysis
           1.3. Industry Challenges
              1.3.1. Presence of Ambiguous Regulatory Framework

  • 6.  Personalized Psychiatry Market Analysis Tools
    •   1. Industry Analysis - Porter’s
           1.1. Supplier Power
           1.2. Buyer Power
           1.3. Substitution Threat
           1.4. Threat from New Entrants
           1.5. Competitive Rivalry
        2. Pestel Analysis
           2.1. Political Landscape
           2.2. Environmental Landscape
           2.3. Social Landscape
           2.4. Application Landscape
           2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
           3.1. Joint Ventures
           3.2. Mergers and Acquisitions
           3.3. Licensing and Partnership
           3.4. Application Collaborations
           3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies

  • 7.  Personalized Psychiatry Market, By Product Type Historical Analysis and Forecast 2024-2032 (USD Million)
    •   1. Software
        2. Services
        3. EEG Biofeedback
        4. Blood Tests
        5. Wearables
        6. Brain Stimulation Devices
        7. Others

  • 8.  Personalized Psychiatry Market, By Condition Historical Analysis and Forecast 2024-2032 (USD Million)
    •   1. Depression & Anxiety
        2. Bipolar Disorder
        3. Addiction
        4. Dementia
        5. ADHD
        6. OCD
        7. Others

  • 9.  Personalized Psychiatry Market, By End-User Historical Analysis and Forecast 2024-2032 (USD Million)
    •   1. Hospitals & Clinics
        2. Academic Institutes & Research Centers
        3. Homecare Settings
        4. Specialty Clinics
        5. Diagnostic Laboratories
        6. Others

  • 10.  North America Personalized Psychiatry Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. U.S.A
           2.2. Canada
           2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2024-2032

  • 11.  Latin America Personalized Psychiatry Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. Brazil
           2.2. Venezuela
           2.3. Argentina
           2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2024-2032

  • 12.  Europe Personalized Psychiatry Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. Germany
           2.2. U.K
           2.3. France
           2.4. Italy
           2.5. Spain
           2.6. Russia
           2.7. Poland
           2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2024-2032

  • 13.  Asia Pacific Personalized Psychiatry Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. Japan
           2.2. China
           2.3. India
           2.4. Australia and New Zealand
           2.5. ASEAN
           2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2024-2032  

  • 14.  Middle East and Africa Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. GCC
           2.2. Israel
           2.3. South Africa
           2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2024-2032

  • 15.  Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix

  • 16.  Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. myStrength
           1.1. Company Overview
           1.2. Product Portfolio
           1.3. SWOT Analysis
           1.4. Financial Overview
           1.5. Strategic Overview
        2. Genomind
           2.1. Company Overview
           2.2. Product Portfolio
           2.3. SWOT Analysis
           2.4. Financial Overview
           2.5. Strategic Overview
        3. WayForward
           3.1. Company Overview
           3.2. Product Portfolio
           3.3. SWOT Analysis
           3.4. Financial Overview
           3.5. Strategic Overview
        4. BrightQuest
           4.1. Company Overview
           4.2. Product Portfolio
           4.3. SWOT Analysis
           4.4. Financial Overview
           4.5. Strategic Overview
        5. Peak Mental Wellness
           5.1. Company Overview
           5.2. Product Portfolio
           5.3. SWOT Analysis
           5.4. Financial Overview
           5.5. Strategic Overview
        6. Mindstrong, Pear Therapeutics
           6.1. Company Overview
           6.2. Product Portfolio
           6.3. SWOT Analysis
           6.4. Financial Overview
           6.5. Strategic Overview
        7. Akili Interactive
           7.1. Company Overview
           7.2. Product Portfolio
           7.3. SWOT Analysis
           7.4. Financial Overview
           7.5. Strategic Overview
        8. Emotiv
           8.1. Company Overview
           8.2. Product Portfolio
           8.3. SWOT Analysis
           8.4. Financial Overview
           8.5. Strategic Overview
        9. Neuronetrix
           9.1. Company Overview
           9.2. Product Portfolio
           9.3. SWOT Analysis
           9.4. Financial Overview
           9.5. Strategic Overview
        10. Medopad
           10.1. Company Overview
           10.2. Product Portfolio
           10.3. SWOT Analysis
           10.4. Financial Overview
           10.5. Strategic Overview
        11. Taliaz
           11.1. Company Overview
           11.2. Product Portfolio
           11.3. SWOT Analysis
           11.4. Financial Overview
           11.5. Strategic Overview
        12. Lucid Lane
           12.1. Company Overview
           12.2. Product Portfolio
           12.3. SWOT Analysis
           12.4. Financial Overview
           12.5. Strategic Overview
        13. MindX Sciences
           13.1. Company Overview
           13.2. Product Portfolio
           13.3. SWOT Analysis
           13.4. Financial Overview
           13.5. Strategic Overview
        14. Neurotrack
           14.1. Company Overview
           14.2. Product Portfolio
           14.3. SWOT Analysis
           14.4. Financial Overview
           14.5. Strategic Overview
        15. 7 Cups
           15.1. Company Overview
           15.2. Product Portfolio
           15.3. SWOT Analysis
           15.4. Financial Overview
           15.5. Strategic Overview
        16. Happify
           16.1. Company Overview
           16.2. Product Portfolio
           16.3. SWOT Analysis
           16.4. Financial Overview
           16.5. Strategic Overview
        17. Quartet
           17.1. Company Overview
           17.2. Product Portfolio
           17.3. SWOT Analysis
           17.4. Financial Overview
           17.5. Strategic Overview
        18. NOCD
           18.1. Company Overview
           18.2. Product Portfolio
           18.3. SWOT Analysis
           18.4. Financial Overview
           18.5. Strategic Overview
        19. Real
           19.1. Company Overview
           19.2. Product Portfolio
           19.3. SWOT Analysis
           19.4. Financial Overview
           19.5. Strategic Overview

  • 17.  Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated
      by administrations
        5. The overall economic slowdown of the developing and developed nations

  • 18.  FutureWise SME Key Takeaway Points for Client
    •     

Partner

Our Clients